PE20100233A1 - Imidazoles sustituidos con heterociclilamida - Google Patents
Imidazoles sustituidos con heterociclilamidaInfo
- Publication number
- PE20100233A1 PE20100233A1 PE2010000032A PE2010000032A PE20100233A1 PE 20100233 A1 PE20100233 A1 PE 20100233A1 PE 2010000032 A PE2010000032 A PE 2010000032A PE 2010000032 A PE2010000032 A PE 2010000032A PE 20100233 A1 PE20100233 A1 PE 20100233A1
- Authority
- PE
- Peru
- Prior art keywords
- formula
- procedure
- reacting
- compound
- phenyl
- Prior art date
Links
- 150000002460 imidazoles Chemical group 0.000 title 1
- 238000000034 method Methods 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 239000003638 chemical reducing agent Substances 0.000 abstract 2
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 abstract 1
- -1 CARBONYL GROUP Chemical group 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000018044 dehydration Effects 0.000 abstract 1
- 238000006297 dehydration reaction Methods 0.000 abstract 1
- 150000004679 hydroxides Chemical class 0.000 abstract 1
- 229910052979 sodium sulfide Inorganic materials 0.000 abstract 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A PROCEDIMIENTOS DE PREPARACION DE COMPUESTOS DERIVADOS DE IMIDAZOL DE FORMULA (I) DONDE R1 ES UN GRUPO DE FORMULA (a) O (b), DONDE R4 Y R5 SON CADA UNO FENILO O HETEROARILO DE 5 O 6 MIEMBROS, R6 Y R7 SON CADA UNO H, METILO O ETILO, * ES EL LUGAR DE UNION AL GRUPO CARBONILO; R2 ES ALQUILO(C1-C6) OPCIONALMENTE SUSTITUIDO; R3 ES FENILO; EN DONDE EL PROCEDIMIENTO (A) COMPRENDE: i) HACER REACCIONAR EL COMPUESTO DE FORMULA (II) CON UN AGENTE REDUCTOR TAL COMO CINC/ACIDO CLORHIDRICO, SULFURO DE SODIO, DICLORURO DE ESTANO, ENTRE OTROS, Y ii) EL PRODUCTO OBTENIDO SE HACE REACCIONAR CON H2N-R3 EN PRESENCIA DE N,N-CARBONILDIIMIDAZOL, FOSGENO, ENTRE OTROS; EL PROCEDIMIENTO (B) COMPRENDE: i) HACER REACCIONAR EL COMPUESTO DE FORMULA (II) CON UN AGENTE REDUCTOR AL IGUAL QUE EN EL PROCEDIMIENTO (A), Y ii) EL PRODUCTO OBTENIDO SE HACE REACCIONAR CON OCN-R3; Y EL PROCEDIMIENTO (C) COMPRENDE: i) HACER REACCIONAR EL COMPUESTO DE FORMULA (V) CON UNA BASE TAL COMO HIDROXIDOS ALCALINOS O CARBONATOS ALCALINOS, EN DONDE R8 ES METILO O ETILO, Y ii) EL PRODUCTO OBTENIDO SE HACE REACCIONAR CON R1-H EN PRESENCIA DE REACTIVOS DE DESHIDRATACION TAL COMO N,N'-DICICLOHEXILCARBODIIMIDA, 1-HIDROXIBENZOTRIAZOL, ENTRE OTROS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005008183A DE102005008183A1 (de) | 2005-02-23 | 2005-02-23 | Heterocyclylamid-substituierte Imidazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20100233A1 true PE20100233A1 (es) | 2010-04-22 |
Family
ID=36675125
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000214A PE20061141A1 (es) | 2005-02-23 | 2006-02-22 | Imidazoles sustituidos con heterociclilamida |
| PE2010000032A PE20100233A1 (es) | 2005-02-23 | 2006-02-22 | Imidazoles sustituidos con heterociclilamida |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000214A PE20061141A1 (es) | 2005-02-23 | 2006-02-22 | Imidazoles sustituidos con heterociclilamida |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7919489B2 (es) |
| EP (1) | EP1853582B1 (es) |
| JP (1) | JP5208522B2 (es) |
| KR (1) | KR101276003B1 (es) |
| CN (1) | CN101128455B (es) |
| AR (1) | AR053141A1 (es) |
| AT (1) | ATE446292T1 (es) |
| AU (1) | AU2006218276C1 (es) |
| BR (1) | BRPI0607995B8 (es) |
| CA (1) | CA2598521C (es) |
| DE (2) | DE102005008183A1 (es) |
| DK (1) | DK1853582T3 (es) |
| ES (1) | ES2333249T3 (es) |
| GT (1) | GT200600077A (es) |
| HN (2) | HN2006007774A (es) |
| IL (1) | IL185050A (es) |
| MX (1) | MX2007010308A (es) |
| MY (1) | MY140543A (es) |
| NO (1) | NO338997B1 (es) |
| NZ (1) | NZ560811A (es) |
| PE (2) | PE20061141A1 (es) |
| PL (1) | PL1853582T3 (es) |
| PT (1) | PT1853582E (es) |
| RU (1) | RU2415851C2 (es) |
| TW (1) | TWI388553B (es) |
| UY (1) | UY29387A1 (es) |
| WO (1) | WO2006089664A2 (es) |
| ZA (1) | ZA200707412B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004015007A1 (de) | 2004-03-26 | 2005-10-13 | Bayer Healthcare Ag | Substituierte Imidazole |
| DE102005008183A1 (de) | 2005-02-23 | 2006-08-31 | Bayer Healthcare Ag | Heterocyclylamid-substituierte Imidazole |
| DE102011101446A1 (de) * | 2011-05-10 | 2012-11-15 | Aicuris Gmbh & Co. Kg | Herstellung von "Dense Bodies" (DB) |
| DE102011113749A1 (de) | 2011-09-14 | 2013-03-14 | Aicuris Gmbh & Co. Kg | Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole |
| CN104610160A (zh) * | 2013-11-04 | 2015-05-13 | 南京大学 | 含哌嗪环的5-硝基咪唑类衍生物及其制备与在抗菌药物中的应用 |
| CN104016925B (zh) * | 2014-06-17 | 2016-03-30 | 遵义医学院 | 4-烷基咪唑-2-羧酸的合成方法 |
| HK1248226A1 (en) | 2015-06-22 | 2018-10-12 | Sumitomo Dainippon Pharma Co., Ltd. | 1,4-disubstituted imidazole derivatives |
| JP6507976B2 (ja) * | 2015-09-30 | 2019-05-08 | 東レ株式会社 | イミダゾール−２−カルボン酸エステル誘導体又はその塩の製造方法 |
| CN116120238B (zh) * | 2023-03-01 | 2023-09-22 | 山东梅奥华卫科技有限公司 | 一种咪唑衍生物的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6342501B1 (en) | 1994-02-25 | 2002-01-29 | The Regents Of The University Of Michigan | Pyrrolo[2,3-d] pyrimidines as antiviral agents |
| CA2290520C (en) * | 1997-05-23 | 2009-01-27 | Bayer Corporation | Inhibition of p38 kinase activity by aryl ureas |
| JP2001521934A (ja) | 1997-11-03 | 2001-11-13 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗炎症薬としての芳香族ヘテロ環式化合物 |
| PT1098885E (pt) * | 1998-07-23 | 2005-01-31 | Fujisawa Pharmaceutical Co | Compostos de imidazole e sua utilizacao como inibidores da desaminase de adenosina |
| JP2002533301A (ja) | 1998-12-09 | 2002-10-08 | ワイス | 置換フェニレンジアミン群を含む、複素環式カルボキサミド含有の、ヘルペスウイルスのチオ尿素インヒビター |
| DE10257358A1 (de) | 2002-12-09 | 2004-07-08 | Bayer Healthcare Ag | Substituierte Pyrrole |
| DE102004015007A1 (de) * | 2004-03-26 | 2005-10-13 | Bayer Healthcare Ag | Substituierte Imidazole |
| EP1745032B1 (en) * | 2004-05-12 | 2013-07-31 | Merck Sharp & Dohme Corp. | CXCR1 and CXCR2 chemokine antagonists |
| DE102005008183A1 (de) | 2005-02-23 | 2006-08-31 | Bayer Healthcare Ag | Heterocyclylamid-substituierte Imidazole |
-
2005
- 2005-02-23 DE DE102005008183A patent/DE102005008183A1/de not_active Ceased
-
2006
- 2006-02-14 ZA ZA200707412A patent/ZA200707412B/xx unknown
- 2006-02-14 BR BRPI0607995A patent/BRPI0607995B8/pt not_active IP Right Cessation
- 2006-02-14 DE DE502006005182T patent/DE502006005182D1/de active Active
- 2006-02-14 CN CN2006800056123A patent/CN101128455B/zh not_active Expired - Fee Related
- 2006-02-14 NZ NZ560811A patent/NZ560811A/en unknown
- 2006-02-14 AU AU2006218276A patent/AU2006218276C1/en not_active Ceased
- 2006-02-14 EP EP06706932A patent/EP1853582B1/de active Active
- 2006-02-14 CA CA2598521A patent/CA2598521C/en not_active Expired - Fee Related
- 2006-02-14 AT AT06706932T patent/ATE446292T1/de active
- 2006-02-14 RU RU2007135277/04A patent/RU2415851C2/ru active
- 2006-02-14 PT PT06706932T patent/PT1853582E/pt unknown
- 2006-02-14 PL PL06706932T patent/PL1853582T3/pl unknown
- 2006-02-14 JP JP2007556526A patent/JP5208522B2/ja not_active Expired - Fee Related
- 2006-02-14 ES ES06706932T patent/ES2333249T3/es active Active
- 2006-02-14 DK DK06706932.8T patent/DK1853582T3/da active
- 2006-02-14 MX MX2007010308A patent/MX2007010308A/es active IP Right Grant
- 2006-02-14 WO PCT/EP2006/001325 patent/WO2006089664A2/de not_active Ceased
- 2006-02-14 KR KR1020077021862A patent/KR101276003B1/ko not_active Expired - Fee Related
- 2006-02-16 GT GT200600077A patent/GT200600077A/es unknown
- 2006-02-20 UY UY29387A patent/UY29387A1/es not_active Application Discontinuation
- 2006-02-21 HN HN2006007774A patent/HN2006007774A/es unknown
- 2006-02-21 MY MYPI20060736A patent/MY140543A/en unknown
- 2006-02-22 AR ARP060100637A patent/AR053141A1/es active IP Right Grant
- 2006-02-22 PE PE2006000214A patent/PE20061141A1/es active IP Right Grant
- 2006-02-22 TW TW095105843A patent/TWI388553B/zh not_active IP Right Cessation
- 2006-02-22 PE PE2010000032A patent/PE20100233A1/es active IP Right Grant
-
2007
- 2007-08-06 IL IL185050A patent/IL185050A/en active IP Right Grant
- 2007-08-20 US US11/894,307 patent/US7919489B2/en not_active Expired - Fee Related
- 2007-09-19 NO NO20074780A patent/NO338997B1/no not_active IP Right Cessation
-
2010
- 2010-01-18 HN HN2010000128A patent/HN2010000128A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009012885A (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene, como sustituyente, grupo fenilo que tiene estructura de ester de acido sulfonico o estructura de amida de acido sulfonico introducida en este, y tiene actividad de enlace al receptor de gluco | |
| BRPI0516911A (pt) | método para a preparação de um composto e composto de anilina | |
| PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
| PE20100233A1 (es) | Imidazoles sustituidos con heterociclilamida | |
| UA101482C2 (ru) | Способ получения 2'-дезокси-5-азацитидина (децитабина) | |
| EA200802142A1 (ru) | Цинковая соль розувастатина | |
| HRP20080493T3 (hr) | Supstituirani kinolinski derivati kao mitotski inhibitori kinezina | |
| PE20070007A1 (es) | Metodos para sintetizar derivados de 6-alquilaminoquinolina | |
| EA200800822A1 (ru) | Конъюгаты гидроксиалкилкрахмала и действующего вещества, полученные химическим лигированием через тиазолидин | |
| AR052067A1 (es) | Proceso para la sintesis de azetidinonas | |
| PE20070792A1 (es) | Derivados lactama lactona como intermediarios en la sintesis de inhibidores de renina | |
| CY1108804T1 (el) | Μεθοδος παρασκευης της 4β-αμινο-4'-δεμεθυλ-4- δεσοξυποδοφυλλοτοξινης. | |
| TW200734038A (en) | Novel dispersant and compositions thereof | |
| AR060962A1 (es) | Proceso de preparacion de derivados de quinazolina e intermediarios de sintesis | |
| BR0212982A (pt) | Processo para preparar um composto, e, composto | |
| AR077332A1 (es) | Procesos para la alquilacion de pirazoles | |
| NO970766D0 (no) | Fremgangsmåte for fremstilling av taxol og derivater derav | |
| PH12014501704B1 (en) | Method for preparing compound by novel michael addition reaction using water or various acids as additive | |
| AR082593A1 (es) | Proceso para la preparacion de pirazoles | |
| AR051936A1 (es) | Proceso para la preparacion de pirazoles | |
| RU2011143755A (ru) | Способ получения производного 1,5-бензодиазепина | |
| WO2003061552A3 (en) | Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone | |
| IL166288A0 (en) | Process for production of formylcyclopropanecarboxylic esters | |
| PE50296A1 (es) | Eter substituido con tiazol y oxazol biciclico | |
| DK2264019T3 (da) | Mellemforbindelser til fremstilling af taxanderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |